Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-03-12 @ 1:49 AM
Study NCT ID:
NCT02052960
Status:
COMPLETED
Last Update Posted:
2021-11-02
First Post:
2014-01-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer
Sponsor:
Glycotope GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GEXMab52201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None